Estrella Immunopharma, Inc.ESLANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank80
3Y CAGR+27.2%
5Y CAGR+59.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+27.2%/yr
Annual compound
5Y CAGR
+59.1%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
10.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.81M | +15.5% |
| 2024 | $2.44M | -23.9% |
| 2023 | $3.20M | +134.0% |
| 2022 | $1.37M | +361.8% |
| 2021 | $296248.00 | +7.2% |
| 2020 | $276462.00 | - |